Showing posts with label populations. Show all posts
Showing posts with label populations. Show all posts

Wednesday, August 17, 2011

Screening for pancreatic cancer in high-risk populations

ScienceDaily (July 25, 2011) — Researchers from New England report in a new study that using a tumor marker, serum CA 19-9, combined with an endoscopic ultrasound if the tumor marker is elevated, is more likely to detect stage 1 pancreatic cancer in a high-risk population than by using the standard means of detection. The study appears in the July issue of GIE: Gastrointestinal Endoscopy, the monthly peer-reviewed scientific journal of the American Society for Gastrointestinal Endoscopy (ASGE).See Also:Health & MedicinePancreatic CancerColon CancerCancerBreast CancerLung CancerProstate CancerReferenceGallstoneMetastasisColorectal cancerRenal cell carcinoma

Pancreatic cancer is the fourth leading cause of cancer death in the United States. Advanced disease at diagnosis correlates directly with worse overall survival. Symptoms of abdominal pain, jaundice, and/or weight loss often do not appear until the tumor is locally advanced or metastatic, at which point effective treatment options are very limited. By contrast, detection and resection of pancreatic cancer, when it is confined to the pancreas (stage 1 disease), improves overall survival. An effective screening protocol is urgently needed to detect earlier stage tumors. Imaging methods that have been used for pancreatic cancer screening include endoscopic ultrasound (EUS), CT, endoscopic retrograde cholangiopancreatography (ERCP) and magnetic resonance imaging/MRCP.

There has been limited success in screening younger populations using the tumor marker CA19-9, so more recent pancreatic cancer screening protocols have focused on high-risk populations. It is estimated that 10 percent of patients in whom pancreatic cancer develops have at least one first-degree relative with the disease. Multiple cohort and case-control studies have demonstrated that a family history of a first-degree relative with pancreatic cancer significantly increases a patient's risk of the development of pancreatic cancer, approximately two to five-fold. The risk of the development of pancreatic cancer increases significantly as the number of affected family members increases. Advanced age is also a significant risk factor, and 93 percent of patients with pancreatic cancer present after the age of 50.

"Our hypothesis was that a high-risk population identified by age and at least one first-degree relative with pancreatic cancer can be successfully screened. Our objective was to determine whether early pancreatic neoplasia can be detected in a high-risk population by using tumor marker CA 19-9 followed by targeted endoscopic ultrasound. We also sought to determine whether this protocol was more likely to detect early stage pancreatic cancer than standard means of detection," said study lead author Richard Zubarik, MD, Fletcher Allen Health Care, University of Vermont. "Our results showed that potentially curative pancreatic adenocarcinoma can be identified with this screening protocol. Stage 1 pancreatic cancer is more likely to be detected by using this screening protocol than by using standard means of detection."

Methods

This prospective cohort study was conducted at the University of Vermont (UVM) and the Dartmouth-Hitchcock Medical Center (DHMC). Patients were enrolled from September 2006 to July 2009. Patients included were between the ages of 50 and 80 and had at least one first-degree relative (parent, sibling, or child) with pancreatic cancer. Enrollment was initiated at age 45 if a patient had two first-degree relatives with pancreatic cancer and at age 40 if the person had a BRCA2 mutation or Peutz-Jeghers syndrome.

Serum CA 19-9 testing was performed on all patients. It was chosen as the initial screening method because it is acceptable to patients, easily obtainable, widely available, inexpensive, and relatively sensitive for the disease. Endoscopic ultrasound was performed only in patients with an elevated CA 19-9 level (a CA 19-9 value greater than 37 U/mL was considered elevated) regardless of whether only one or more than one family member was affected with pancreatic cancer.

Patients who were diagnosed with pancreatic cancer at UVM (but were not enrolled in the CA 19-9/EUS study) during the same period were prospectively identified and used as the comparison group. These patients were identified by the Cancer Data Registry at the University of Vermont. Charts were then reviewed to verify tumor type, staging data and survival.

Results

A total of 546 patients were enrolled in the study. CA 19-9 was elevated in 27 patients (4.9 percent). Neoplastic or malignant findings were detected in five patients (0.9 percent), and pancreatic cancer in one patient (0.2 percent). The patient with pancreatic cancer detected as part of this study was one of two patients presenting to the University of Vermont with stage 1 cancer. One-year follow-up contact was performed by telephone in 519 patients (95 percent), by chart review in 24 patients (four percent), and by review of the social security death index in three patients (less than one percent). Pancreatic cancer was not detected at the one-year follow-up in any additional patients.

In the comparison group, a total of 124 patients received a diagnosis of pancreatic cancer between September 2006 and July 2009. Staging of the comparison group at the time of presentation was as follows: stage 1, one patient (0.9 percent); stage 2, 52 patients (45.6 percent); stage 3, 20 patients (17.5 percent); stage 4, 41 patients (36 percent). The patient detected in the CA 19-9/EUS study had stage 1 disease, whereas only 0.9 percent of patients in the comparison group presented with stage 1 disease. This difference was statistically significant despite only having one patient with pancreatic cancer detected in the study group because the detection of stage 1 cancer in the comparison group was so rare. Median survival for the 122 subjects in the comparison group was seven months, with a 2-year survival rate of 10 percent.

The results conclude that potentially curative pancreatic cancer can be identified with CA 19-9 and targeted EUS. Stage 1 pancreatic cancer is more likely to be detected by using this screening protocol than by using standard means of detection. Potential advantages include acceptable rates of disease diagnosis and exclusion as well as acceptable costs (cost to detect 1 pancreatic neoplasia was $8,431, while the cost to detect 1 pancreatic cancer was $41,133). In particular, the patient with pancreatic cancer detected with this screening protocol is alive without evidence of recurrence three years after surgical resection and is the longest survivor of pancreatic cancer detected in a published screening protocol. Also, evidence of pancreatic cancer did not develop in subjects with negative screening studies, at least in short-term follow-up.

The researchers note that the sample size is adequate only to demonstrate the feasibility of this approach, but summarized that this trial successfully screened a high-risk patient population for pancreatic cancer based on age and genetic predisposition. Early pancreatic cancer, associated with prolonged disease-free survival, can be detected as part of this pancreatic screening protocol. Stage 1 pancreatic cancer was more likely to be detected with CA 19-9 and targeted EUS, and it appears to be superior to the standard means of pancreatic cancer detection.

Email or share this story:

Sunday, August 14, 2011

Identical virus, host populations can prevail for centuries

ScienceDaily (July 22, 2011) — A Woods Hole Oceanographic Institution (WHOI) scientist, analyzing ancient plankton DNA signatures in sediments of the Black Sea, has found for the first time that the same genetic populations of a virus and its algal host can persist and coexist for centuries. The findings have implications for the ecological significance of viruses in shaping algae ecosystems in the ocean, and perhaps fresh water as well.See Also:Plants & AnimalsVirologyMicrobes and MoreNatureEarth & ClimateGlobal WarmingClimateEcologyReferenceAlgal bloomVector (biology)Coral bleachingProtozoa

"The finding that the DNA of viruses and algal host cells can be preserved in the geological records is of great interest to microbial ecologists," said Marco Coolen of WHOI's Marine Chemistry and Geochemistry department and author of the study, which appears in the July 22 issue of Science. "This offers unprecedented insights into long-term algal, viral, and host population dynamics between globally important algae and their viral pathogens in the ocean."

In examining the 7,000-year continuous genetic record in sediments underlying the Black Sea, Coolen discovered that the DNA of both the Coccolithovirus and its host, Emiliania huxleyi, a phytoplankton that plays a major role in the global carbon cycle, have been preserved over thousands of years.

"Biologists now for the first time have a picture of long-term viral/host dynamics in the ocean," Coolen said. Previous laboratory work had confirmed such co-existence for only a few successive years.

Coolen added that much longer virus/host records such as the ones he studied, for the first time "could answer important questions, such as: 'What factors are involved in controlling viral infection of the globally important marine algae and how long can the same host and virus populations co-exist?' and 'Were past algal populations only controlled by the prevailing environmental conditions or did viruses also play an important role in shaping past algal community structures?'"

The latter question is of particular interest, Coolen said, because "nobody has long-term records of viruses. Ecological shifts in past algal communities are generally explained by changes in climate and environmental conditions." Now it seems possible, he said, that viruses also played an important role in shaping past algal communities.

This is important for E. huxleyi, which performs photosynthesis -- "just like plants," says WHOI scientist Benjamin Van Mooy. "They consume carbon dioxide." In doing so, they reduce the amount of CO2 released into the atmosphere. They form a calcium carbonate shell, also helping to regulate the carbon cycle.

But DNA viruses of the genus Coccolithovirus kill off large populations of E. huxleyi, particularly in the North Atlantic. Van Mooy has traced this phenomenon to lipids, or fatty compounds, in certain viruses. If viruses are killing off phytoplankton, this can increase greenhouse emissions, Van Mooy suggests. "That's important because if viruses infect a whole bunch of cells, then they can't perform photosynthesis, they can't take up carbon dioxide."

Coolen says his data buttress Van Mooy's work by suggesting a significant role for viruses in affecting the algal population and carbon cycling in the past. He observed, for example, major shifts in the types of Coccolithovirus and E. huxleyi in the Black Sea sediments over the centuries. Environmental conditions almost certainly had a role in selecting successful E. huxleyi genotypes, but Coolen believes viruses may have as well.

"Until now, shifts in past plankton species identified through the microscopic analysis of preserved diagnostic cellular fossils have mainly been linked to changes in environmental conditions and climate," Coolen said. "However, understanding the viral role in controlling past algal stocks is necessary to improve the interpretation of past climate records. This can now be studied using ancient DNA methods."

One thing that enabled Coolen to study sediments so far back in time was the continuous absence of oxygen in the bottom waters of the Black Sea the last 7,500 years. "This lack of oxygen facilitated the preservation of organic material in general and ancient viral and algal plankton DNA in particular," he said.

In addition, unpublished data from Coolen's lab "show that Black Sea sediments older than 7,500 years contain well-preserved DNA of a different suite of algae adapted to lower salinities and freshwater environments and likely also DNA of their viral pathogens," he said. "In other words, comparable studies could most likely be employed in a wide variety of marine and lake ecosystems.

"In a different and broader context," he adds, "it will perhaps be possible to reconstruct the historical spread of human viral diseases since a variety of human viral infections are also caused by DNA viruses."

The research was funded by grants from the National Science Foundation (NSF) and a grant from the Andrew W. Mellon Foundation.

Email or share this story: